Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer

NCT05928312 · clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
72
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Zhejiang Cancer Hospital